HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice.

Abstract
Magnesium (Mg) deficiency increases genomic instability and Mg intake has been reported to be inversely associated with a risk of colorectal cancer (CRC). This study was designed to determine whether organo-Mg in drinking water suppresses inflammation-associated colon carcinogenesis in mice. Male Crj: CD-1 mice were initiated with a single i.p. injection of azoxymethane (AOM, 10mg/kg body weight) and followed by a 1 week exposure to dextran sulfate sodium (DSS, 1.5%, w/v) in drinking water to induce colonic neoplasms. They were then given the drinking water containing 7, 35 or 175 p.p.m. organo-Mg for 13 weeks. The chemopreventive efficacy of organo-Mg was determined 16 weeks after the AOM exposure. Administration with organo-Mg at all doses caused a significant inhibition of CRC development (P < 0.01 and P < 0.001). Especially, the highest dose of organo-Mg significantly suppressed the occurrence of all the colonic pathological lesions (mucosal ulcer, dysplasia, adenoma and adenocarcinoma). Organo-Mg also significantly reduced the number of mitoses/anaphase bridging, as well as proliferation of CRC. Additionally, at week 4, organo-Mg lowered the messenger RNA expression of certain proinflammatory cytokines, such as interleukin-1β, interleukin-6, interferon-γ and inducible nitric oxide synthase in the lesion-free colorectal mucosa at week 4 but increased the Nrf-2 messenger RNA expression. Our findings that organo-Mg inhibits inflammation-related mouse colon carcinogenesis by modulating the proliferative activities and chromosomal instability of CRC and suppressing colonic inflammation may suggest potential use of organo-Mg for clinical chemoprevention trials of CRC in the inflamed colon.
AuthorsToshiya Kuno, Yuichiro Hatano, Hiroyuki Tomita, Akira Hara, Yoshinobu Hirose, Akihiro Hirata, Hideki Mori, Masaru Terasaki, Sonoko Masuda, Takuji Tanaka
JournalCarcinogenesis (Carcinogenesis) Vol. 34 Issue 2 Pg. 361-9 (Feb 2013) ISSN: 1460-2180 [Electronic] England
PMID23125223 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carcinogens
  • Interleukin-1beta
  • Interleukin-6
  • Magnesium Compounds
  • Organometallic Compounds
  • RNA, Messenger
  • Recombinant Proteins
  • interferon gamma-1b
  • Interferon-gamma
  • Dextran Sulfate
  • Azoxymethane
Topics
  • Adenocarcinoma (chemically induced, immunology, prevention & control)
  • Adenoma (chemically induced, immunology, prevention & control)
  • Animals
  • Apoptosis (drug effects)
  • Azoxymethane (toxicity)
  • Blotting, Western
  • Carcinogens (toxicity)
  • Cell Proliferation (drug effects)
  • Cell Transformation, Neoplastic (drug effects)
  • Colitis (chemically induced, immunology, prevention & control)
  • Colonic Neoplasms (chemically induced, immunology, prevention & control)
  • Dextran Sulfate (toxicity)
  • Humans
  • Immunoenzyme Techniques
  • Inflammation (chemically induced, immunology, prevention & control)
  • Interferon-gamma (genetics, metabolism)
  • Interleukin-1beta (genetics, metabolism)
  • Interleukin-6 (genetics, metabolism)
  • Magnesium Compounds (pharmacology)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mitotic Index
  • Organometallic Compounds (pharmacology)
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Recombinant Proteins (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: